CAPTRUST Financial Advisors’s Rallybio RLYB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,250
Closed -$6.86K 3110
2025
Q4
$6.86K Hold
1,250
﹤0.01% 2731
2025
Q3
$4.99K Hold
1,250
﹤0.01% 2620
2025
Q2
$3.38K Hold
1,250
﹤0.01% 2505
2025
Q1
$6.54K Hold
1,250
﹤0.01% 2345
2024
Q4
$9.6K Hold
1,250
﹤0.01% 2281
2024
Q3
$11.7K Sell
1,250
-12
-1% -$116 ﹤0.01% 2269
2024
Q2
$13.5K Buy
1,262
+8
+0.6% +$108 ﹤0.01% 2179
2024
Q1
$18.6K Buy
+1,254
New +$17.5K ﹤0.01% 2114

Other funds holding RLYB

CAPTRUST Financial Advisors's RLYB Position: Q1 2026 in Review

CAPTRUST Financial Advisors sold out of Rallybio (RLYB) in Q1 2026, closing a stake of 1,250 shares — an estimated $6.86K sold.

CAPTRUST Financial Advisors first reported a position in RLYB in Q1 2024 and held it in 8 quarters. The position peaked at $18.6K in Q1 2024. 38 funds tracked by Wall St. Rank hold RLYB as of Q1 2026.

  • CAPTRUST Financial Advisors reported no remaining Rallybio position as of Q1 2026 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 1,250 Rallybio shares in Q1 2026, an estimated $6.86K.
  • CAPTRUST Financial Advisors first reported a position in Rallybio in Q1 2024 and held it in 8 quarters.
  • CAPTRUST Financial Advisors's Rallybio position peaked at $18.6K in Q1 2024.
  • 38 funds tracked by Wall St. Rank held Rallybio as of Q1 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q1 2026, filed 15 May 2026.